Trials / Not Yet Recruiting
Not Yet RecruitingNCT05833971
Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma
A Single-arm, Multicenter, Exploratory Study of Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (estimated)
- Sponsor
- Guangzhou Institute of Respiratory Disease · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, multicenter, exploratory study to evaluate the efficacy and safety of AK104 in combination with cisplatin and paclitaxel in the treatment of resectable locally advanced esophageal squamous carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cadonilimab+chemotherapy | cadonilimab plus cisplatin and Nab-PTX, Q3W |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-06-01
- Completion
- 2026-06-01
- First posted
- 2023-04-27
- Last updated
- 2023-04-27
Source: ClinicalTrials.gov record NCT05833971. Inclusion in this directory is not an endorsement.